Fate Therapeutics
FATE
FATE
147 hedge funds and large institutions have $1.41B invested in Fate Therapeutics in 2019 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 58 increasing their positions, 35 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
13% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 30
1% less funds holding
Funds holding: 149 → 147 (-2)
2.46% less ownership
Funds ownership: 97.98% → 95.52% (-2.5%)
Holders
147
Holding in Top 10
7
Calls
$13.3M
Puts
$8.71M
Top Buyers
| 1 | +$11.2M | |
| 2 | +$10.5M | |
| 3 | +$8.83M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$8.76M |
| 5 |
Morgan Stanley
New York
|
+$7.51M |
Top Sellers
| 1 | -$34.8M | |
| 2 | -$13.7M | |
| 3 | -$11.1M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$10.9M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$7.78M |